POLYETHYLENE GLYCOL (3350)

POLYETHYLENE GLYCOL (3350) was reported 96561 times

POLYETHYLENE GLYCOL (3350) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTACID THERAPY 80 0.6154
1 SLEEP DISORDER THERAPY 120 0.6061
2 APPENDICOLITH 215 0.5556
3 MEDICALLY INDUCED PRETERM BIRTH 7 0.4375
4 ANALGESIC THERAPY 123 0.3832
5 DRUG THERAPY 115 0.3392
6 ANTICOAGULANT THERAPY 79 0.2782
7 CONGENITAL HIATUS HERNIA 57 0.2500
8 EXPOSURE TO UNSPECIFIED AGENT 46 0.2347
9 VAGINAL FLATULENCE 70 0.2310
10 MALIGNANT MELANOMA STAGE 0 44 0.2105
11 FOREIGN BODY INGESTION 15 0.1339
12 BINOCULAR EYE MOVEMENT DISORDER 34 0.1181
13 BACTEROIDES INFECTION 30 0.1149
14 CEREBRAL HYPOPERFUSION 50 0.1073
15 VICTIM OF CHILD ABUSE 24 0.0960
16 CEREBELLAR STROKE 34 0.0870
17 CHILD ABUSE 20 0.0772
18 NEUTROPENIA NEONATAL 17 0.0759
19 HYPERPHOSPHATAEMIA 159 0.0739
20 PELVIC KIDNEY 8 0.0690
21 EPIDURAL LIPOMATOSIS 23 0.0669
22 BLOOD PHOSPHORUS INCREASED 178 0.0651
23 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 55 0.0593
24 INCORRECT PRODUCT ADMINISTRATION DURATION 1269 0.0585
25 CEREBRAL ARTERY THROMBOSIS 27 0.0525
26 BRAIN SCAN ABNORMAL 27 0.0484
27 FEMALE GENITAL TRACT FISTULA 72 0.0421
28 NASAL HERPES 8 0.0394
29 SICCA SYNDROME 7 0.0363
30 HYPONATRAEMIC SEIZURE 8 0.0315
31 CHRONIC SINUSITIS 117 0.0311
32 NONINFECTIOUS PERITONITIS 7 0.0288
33 CATARRH 26 0.0288
34 PROCTITIS 78 0.0278
35 TOTAL LUNG CAPACITY DECREASED 44 0.0275
36 RADICULOPATHY 71 0.0269
37 STEROID DEPENDENCE 23 0.0262
38 IRON DEFICIENCY 115 0.0255
39 BLOOD URIC ACID INCREASED 146 0.0253
40 FOETAL DISORDER 21 0.0251
41 APPENDICITIS 221 0.0236
42 INCORRECT DRUG ADMINISTRATION DURATION 625 0.0222
43 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 110 0.0217
44 GINGIVAL ABSCESS 16 0.0212
45 AORTIC STENOSIS 73 0.0209
46 FAECAL VOLUME DECREASED 10 0.0208
47 HYPOPHOSPHATAEMIA 152 0.0205
48 MYASTHENIA GRAVIS 159 0.0197
49 HYPORESPONSIVE TO STIMULI 23 0.0196
50 VENTRICULAR FIBRILLATION 211 0.0190
51 DIABETIC KETOSIS 7 0.0184
52 LUNG OPACITY 46 0.0174
53 BURNS SECOND DEGREE 28 0.0159
54 PLEURITIC PAIN 44 0.0159
55 CARDIOGENIC SHOCK 222 0.0155
56 SCIATIC NERVE INJURY 12 0.0144
57 PNEUMONIA HAEMOPHILUS 7 0.0144
58 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 87 0.0143
59 MACULAR DEGENERATION 165 0.0138
60 THERAPEUTIC PRODUCT EFFECT VARIABLE 51 0.0131
61 SLOW RESPONSE TO STIMULI 17 0.0131
62 RESPIRATORY SYMPTOM 36 0.0126
63 TROPONIN INCREASED 91 0.0119
64 THERAPEUTIC PRODUCT EFFECT DELAYED 54 0.0118
65 INTESTINAL PSEUDO-OBSTRUCTION 10 0.0114
66 BREATH SOUNDS ABNORMAL 56 0.0113
67 TONGUE PARALYSIS 8 0.0112
68 OESOPHAGEAL ACHALASIA 7 0.0109
69 ENTEROCOCCUS TEST POSITIVE 7 0.0108
70 BLOOD PRESSURE DIASTOLIC ABNORMAL 27 0.0106
71 PSEUDOMONAL BACTERAEMIA 9 0.0105
72 AREFLEXIA 28 0.0105
73 BENIGN PROSTATIC HYPERPLASIA 54 0.0104
74 FAECES SOFT 76 0.0104
75 BLISTER INFECTED 8 0.0102
76 ALCOHOL POISONING 27 0.0101
77 PRODUCT AFTER TASTE 9 0.0094
78 NEUTROPENIC INFECTION 9 0.0094
79 JUVENILE IDIOPATHIC ARTHRITIS 23 0.0094
80 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 25 0.0094
81 BACTERIAL INFECTION 175 0.0094
82 BLOOD CALCIUM INCREASED 81 0.0092
83 FAECALOMA 50 0.0091
84 ANAL INCONTINENCE 82 0.0091
85 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 155 0.0090
86 MULTIPLE ORGAN DYSFUNCTION SYNDROME 241 0.0085
87 HYPOPNOEA 29 0.0083
88 MICTURITION URGENCY 95 0.0083
89 NEURALGIA 200 0.0082
90 FREQUENT BOWEL MOVEMENTS 222 0.0082
91 HYPERLIPIDAEMIA 98 0.0082
92 UNDERDOSE 598 0.0082
93 ASCITES 240 0.0082
94 MYCOBACTERIAL INFECTION 14 0.0081
95 ABNORMAL FAECES 66 0.0080
96 BRONCHIECTASIS 53 0.0079
97 MUSCLE NECROSIS 7 0.0077
98 BLOOD PRESSURE SYSTOLIC ABNORMAL 19 0.0077
99 PSYCHIATRIC DECOMPENSATION 15 0.0077
100 ON AND OFF PHENOMENON 42 0.0076
101 VAGINAL DISCHARGE 76 0.0075
102 KLEBSIELLA BACTERAEMIA 7 0.0074
103 PARAESTHESIA ORAL 105 0.0073
104 DRUG EFFECT LESS THAN EXPECTED 107 0.0072
105 DRUG EFFECT VARIABLE 8 0.0071
106 FAECES HARD 27 0.0069
107 RECTAL PROLAPSE 8 0.0066
108 RESPIRATORY ACIDOSIS 26 0.0066
109 HEPATIC CYTOLYSIS 84 0.0066
110 FRACTURED SACRUM 8 0.0064
111 HYPONATRAEMIA 362 0.0064
112 RENAL MASS 13 0.0063
113 TROPONIN T INCREASED 8 0.0063
114 EXPIRED PRODUCT ADMINISTERED 207 0.0062
115 ORAL CANDIDIASIS 82 0.0062
116 PNEUMONIA VIRAL 19 0.0060
117 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 42 0.0059
118 ULCER 93 0.0058
119 ASPIRATION 64 0.0058
120 GOUT 103 0.0057
121 MONOCYTE COUNT DECREASED 7 0.0057
122 VASCULAR PURPURA 8 0.0057
123 HYPERCAPNIA 17 0.0056
124 BICYTOPENIA 11 0.0056
125 DYSCHEZIA 17 0.0056
126 END STAGE RENAL DISEASE 101 0.0055
127 BLOOD TEST ABNORMAL 77 0.0055
128 FRUSTRATION TOLERANCE DECREASED 44 0.0054
129 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 9 0.0054
130 APLASTIC ANAEMIA 28 0.0054
131 ABDOMINAL DISTENSION 541 0.0052
132 CARBON DIOXIDE INCREASED 7 0.0051
133 AUTONOMIC NERVOUS SYSTEM IMBALANCE 15 0.0051
134 CARDIAC MURMUR 44 0.0051
135 VASCULAR DEVICE INFECTION 23 0.0051
136 RASH MORBILLIFORM 14 0.0050
137 INTESTINAL ULCER 8 0.0050
138 CLOSTRIDIUM TEST POSITIVE 11 0.0050
139 INTENSIVE CARE 7 0.0049
140 SWOLLEN TONGUE 151 0.0048
141 FLATULENCE 274 0.0048
142 BEHAVIOUR DISORDER 26 0.0048
143 WRONG PATIENT RECEIVED PRODUCT 14 0.0048
144 FULL BLOOD COUNT ABNORMAL 50 0.0047
145 HYPERCHOLESTEROLAEMIA 45 0.0047
146 LUNG CONSOLIDATION 13 0.0046
147 ANTIPSYCHOTIC DRUG LEVEL INCREASED 13 0.0046
148 CHOLESTATIC LIVER INJURY 10 0.0045
149 ANAL FISSURE 24 0.0045
150 HEPATIC LESION 19 0.0044
151 MIXED LIVER INJURY 13 0.0043
152 RALES 25 0.0043
153 DYSENTERY 8 0.0043
154 THERAPEUTIC PRODUCT EFFECT DECREASED 190 0.0042
155 JAUNDICE NEONATAL 8 0.0042
156 PANCREATIC CYST 8 0.0042
157 CEREBELLAR SYNDROME 9 0.0041
158 RED CELL DISTRIBUTION WIDTH INCREASED 17 0.0041
159 PYELONEPHRITIS ACUTE 8 0.0041
160 RHINITIS 32 0.0040
161 INTRACRANIAL PRESSURE INCREASED 22 0.0039
162 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 206 0.0039
163 IRON DEFICIENCY ANAEMIA 36 0.0039
164 FEBRILE NEUTROPENIA 258 0.0039
165 NOCTURIA 47 0.0039
166 FACIAL PARALYSIS 33 0.0039
167 CUTANEOUS VASCULITIS 14 0.0038
168 BLOOD CREATININE DECREASED 12 0.0038
169 ESSENTIAL HYPERTENSION 7 0.0038
170 PROCEDURAL PAIN 105 0.0038
171 GINGIVAL PAIN 30 0.0038
172 PROCTALGIA 24 0.0037
173 ISCHAEMIC STROKE 66 0.0037
174 SPUTUM DISCOLOURED 35 0.0037
175 RHINOVIRUS INFECTION 14 0.0036
176 BLOOD CHOLESTEROL INCREASED 167 0.0036
177 PAROSMIA 27 0.0036
178 APHTHOUS ULCER 27 0.0035
179 CONSTIPATION 747 0.0034
180 RECTAL HAEMORRHAGE 147 0.0034
181 ESCHERICHIA BACTERAEMIA 8 0.0034
182 FAECES DISCOLOURED 73 0.0034
183 HEMIPLEGIA 28 0.0034
184 SUSPECTED OFF LABEL USE 15 0.0033
185 CYTOKINE RELEASE SYNDROME 65 0.0032
186 ANAL HAEMORRHAGE 9 0.0032
187 ENDOTRACHEAL INTUBATION 9 0.0032
188 MICTURITION DISORDER 11 0.0032
189 TOXIC ENCEPHALOPATHY 16 0.0032
190 MEAN CELL VOLUME INCREASED 8 0.0031
191 SEPSIS 345 0.0031
192 THERAPEUTIC REACTION TIME DECREASED 9 0.0031
193 GENERAL PHYSICAL HEALTH DETERIORATION 354 0.0031
194 FEBRILE BONE MARROW APLASIA 13 0.0031
195 DRUG INTOLERANCE 295 0.0031
196 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 18 0.0030
197 BLOOD PRESSURE DIASTOLIC INCREASED 14 0.0030
198 HAEMATOCHEZIA 167 0.0030
199 EOSINOPHILIA 53 0.0030
200 BOWEL MOVEMENT IRREGULARITY 23 0.0030
201 DYSPHONIA 175 0.0030
202 LARGE INTESTINAL ULCER 8 0.0029
203 SMALL INTESTINAL OBSTRUCTION 36 0.0029
204 TYPE IV HYPERSENSITIVITY REACTION 8 0.0029
205 COLITIS 110 0.0029
206 PRODUCT PRESCRIBING ERROR 69 0.0029
207 PRODUCT PREPARATION ISSUE 19 0.0029
208 PULMONARY EMBOLISM 271 0.0028
209 FEELING COLD 79 0.0028
210 HYPOALBUMINAEMIA 22 0.0028
211 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 154 0.0028
212 HEART VALVE INCOMPETENCE 8 0.0028
213 RESPIRATORY DEPRESSION 34 0.0028
214 LOW BIRTH WEIGHT BABY 22 0.0028
215 STAPHYLOCOCCAL BACTERAEMIA 12 0.0028
216 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 15 0.0028
217 DRY MOUTH 223 0.0027
218 PULMONARY PAIN 8 0.0027
219 DYSPHEMIA 12 0.0027
220 HYPOXIA 96 0.0027
221 DRUG LEVEL BELOW THERAPEUTIC 15 0.0027
222 MENOPAUSE 7 0.0027
223 DEFAECATION URGENCY 19 0.0027
224 CATHETER SITE PAIN 7 0.0027
225 OBSTRUCTIVE AIRWAYS DISORDER 30 0.0027
226 ANGIOEDEMA 119 0.0027
227 ABDOMINAL PAIN 622 0.0027
228 PRODUCT ADMINISTRATION ERROR 54 0.0027
229 COLITIS ULCERATIVE 119 0.0027
230 HEPATITIS CHOLESTATIC 16 0.0027
231 BODY TEMPERATURE DECREASED 26 0.0026
232 SLEEP DISORDER 186 0.0026
233 GASTROINTESTINAL MOTILITY DISORDER 14 0.0026
234 BLOOD PRESSURE SYSTOLIC INCREASED 51 0.0026
235 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 471 0.0026
236 JOINT INJURY 55 0.0026
237 IMPAIRED QUALITY OF LIFE 37 0.0026
238 TRANSAMINASES INCREASED 57 0.0026
239 LIVER FUNCTION TEST INCREASED 55 0.0026
240 DEPRESSIVE SYMPTOM 9 0.0026
241 PULMONARY MASS 38 0.0025
242 PRESYNCOPE 62 0.0025
243 HYDRONEPHROSIS 19 0.0025
244 RASH MACULO-PAPULAR 56 0.0025
245 DIVERTICULUM INTESTINAL 11 0.0025
246 PERIORBITAL SWELLING 14 0.0025
247 HOSPICE CARE 24 0.0024
248 MUCOUS STOOLS 12 0.0024
249 GASTROINTESTINAL SOUNDS ABNORMAL 12 0.0024
250 HYPERNATRAEMIA 12 0.0024
251 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 170 0.0024
252 DRUG EFFECT DECREASED 127 0.0024
253 INTENTIONAL PRODUCT MISUSE 206 0.0024
254 DIABETES MELLITUS 179 0.0023
255 BLOOD CULTURE POSITIVE 7 0.0023
256 BLOOD CREATININE INCREASED 151 0.0023
257 ATELECTASIS 22 0.0023
258 HYPOKALAEMIA 105 0.0023
259 LEUKOCYTOSIS 41 0.0023
260 INFUSION SITE ERYTHEMA 19 0.0023
261 THROMBOSIS 181 0.0022
262 ANAEMIA 429 0.0022
263 COLITIS ISCHAEMIC 15 0.0022
264 LYMPHOCYTE COUNT DECREASED 39 0.0022
265 DRUG EFFECT DELAYED 10 0.0022
266 TIC 12 0.0022
267 BACTERAEMIA 26 0.0022
268 HYPERURICAEMIA 9 0.0022
269 ENTERITIS 14 0.0022
270 GASTROINTESTINAL PAIN 24 0.0022
271 CLOSTRIDIUM DIFFICILE COLITIS 23 0.0022
272 DIZZINESS POSTURAL 21 0.0022
273 POSTURE ABNORMAL 7 0.0021
274 BLOOD ALBUMIN DECREASED 17 0.0021
275 INFUSION RELATED REACTION 142 0.0021
276 GENERAL SYMPTOM 16 0.0021
277 INFUSION SITE HAEMORRHAGE 7 0.0021
278 SWELLING FACE 138 0.0021
279 SKIN ABRASION 10 0.0021
280 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 7 0.0021
281 SINUS TACHYCARDIA 30 0.0021
282 TENDERNESS 22 0.0021
283 LEFT VENTRICULAR HYPERTROPHY 9 0.0021
284 GENERALISED OEDEMA 26 0.0021
285 TRANSFUSION 22 0.0021
286 PYELONEPHRITIS 18 0.0021
287 HYPOKINESIA 30 0.0021
288 NEUTROPHIL COUNT INCREASED 21 0.0020
289 ACUTE RESPIRATORY FAILURE 39 0.0020
290 OBESITY 32 0.0020
291 LOWER RESPIRATORY TRACT INFECTION 91 0.0020
292 IMPAIRED GASTRIC EMPTYING 27 0.0020
293 VITAMIN B12 DEFICIENCY 8 0.0020
294 SWELLING 184 0.0020
295 INTESTINAL OBSTRUCTION 74 0.0020
296 TUBULOINTERSTITIAL NEPHRITIS 36 0.0019
297 CORONARY ARTERY DISEASE 58 0.0019
298 RESPIRATORY RATE INCREASED 17 0.0019
299 PULSELESS ELECTRICAL ACTIVITY 8 0.0019
300 INFUSION SITE SWELLING 12 0.0019
301 HALLUCINATIONS, MIXED 8 0.0019
302 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 135 0.0019
303 GAMMA-GLUTAMYLTRANSFERASE INCREASED 42 0.0019
304 ANORECTAL DISCOMFORT 10 0.0019
305 MALNUTRITION 21 0.0019
306 FAECAL INCONTINENCE 9 0.0019
307 HAEMOGLOBIN ABNORMAL 12 0.0019
308 GLUCOSE TOLERANCE IMPAIRED 11 0.0019
309 ABDOMINAL PAIN LOWER 47 0.0019
310 NEUROLEPTIC MALIGNANT SYNDROME 22 0.0019
311 DIPLOPIA 48 0.0018
312 INCORRECT DOSE ADMINISTERED 419 0.0018
313 ENCEPHALOPATHY 45 0.0018
314 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 88 0.0018
315 HAEMOPTYSIS 51 0.0018
316 URINARY RETENTION 61 0.0018
317 UPPER RESPIRATORY TRACT INFECTION 84 0.0018
318 DIABETIC NEUROPATHY 9 0.0018
319 ASPARTATE AMINOTRANSFERASE INCREASED 96 0.0018
320 CYSTIC FIBROSIS 10 0.0018
321 MUSCLE RUPTURE 7 0.0018
322 ILEUS PARALYTIC 8 0.0018
323 RESPIRATORY DISTRESS 49 0.0018
324 HALLUCINATION, VISUAL 37 0.0018
325 IMMUNE THROMBOCYTOPENIA 8 0.0017
326 PLEURAL EFFUSION 106 0.0017
327 HEART RATE DECREASED 61 0.0017
328 HYPERTRANSAMINASAEMIA 12 0.0017
329 BLOOD POTASSIUM INCREASED 28 0.0017
330 AGRANULOCYTOSIS 32 0.0017
331 BLADDER DISORDER 17 0.0017
332 ABDOMINAL PAIN UPPER 349 0.0017
333 TRANSIENT ISCHAEMIC ATTACK 57 0.0017
334 SOMNOLENCE 339 0.0017
335 BRONCHOSPASM 24 0.0017
336 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 13 0.0017
337 CHOLESTASIS 32 0.0017
338 HAEMATOCRIT DECREASED 33 0.0017
339 HUMERUS FRACTURE 8 0.0017
340 BURSITIS 20 0.0016
341 STREPTOCOCCAL INFECTION 9 0.0016
342 ABDOMINAL TENDERNESS 8 0.0016
343 IMMUNODEFICIENCY 24 0.0016
344 INTESTINAL PERFORATION 18 0.0016
345 PNEUMONIA ASPIRATION 40 0.0016
346 DYSARTHRIA 60 0.0016
347 PARONYCHIA 7 0.0016
348 PRODUCT SOLUBILITY ABNORMAL 8 0.0016
349 ACUTE KIDNEY INJURY 242 0.0016
350 ESCHERICHIA INFECTION 13 0.0016
351 CARDIOVASCULAR DISORDER 40 0.0016
352 DRUG LEVEL DECREASED 16 0.0016
353 DYSPEPSIA 154 0.0016
354 HYPOPHAGIA 40 0.0016
355 CONDITION AGGRAVATED 475 0.0016
356 SKIN REACTION 22 0.0016
357 PRODUCTIVE COUGH 74 0.0015
358 FAILURE TO THRIVE 8 0.0015
359 HERPES SIMPLEX 10 0.0015
360 HYPOVOLAEMIA 9 0.0015
361 ABDOMINAL HERNIA 7 0.0015
362 THROMBOCYTOPENIA 171 0.0015
363 OFF LABEL USE 1338 0.0015
364 MUCOSAL INFLAMMATION 40 0.0015
365 LUMBAR VERTEBRAL FRACTURE 7 0.0015
366 UROSEPSIS 14 0.0015
367 PLEURISY 9 0.0015
368 OSTEOPENIA 23 0.0015
369 HYPERKALAEMIA 53 0.0015
370 SPEECH DISORDER 79 0.0015
371 PERFORMANCE STATUS DECREASED 7 0.0015
372 ARTERIOSCLEROSIS 14 0.0015
373 URINE OUTPUT DECREASED 13 0.0015
374 SHOCK HAEMORRHAGIC 12 0.0015
375 INTENTIONAL PRODUCT USE ISSUE 129 0.0015
376 CLOSTRIDIUM DIFFICILE INFECTION 32 0.0015
377 PULMONARY FIBROSIS 28 0.0015
378 ENTEROCOCCAL INFECTION 7 0.0014
379 DROOLING 10 0.0014
380 HYPOTENSION 289 0.0014
381 VITAMIN D DEFICIENCY 14 0.0014
382 HAEMORRHOIDAL HAEMORRHAGE 7 0.0014
383 FOOD ALLERGY 11 0.0014
384 DELUSION 22 0.0014
385 CONFUSIONAL STATE 228 0.0014
386 PROTEIN URINE PRESENT 7 0.0014
387 DIARRHOEA 904 0.0014
388 VOMITING 658 0.0014
389 BLOOD POTASSIUM DECREASED 42 0.0014
390 CONTRAINDICATED PRODUCT ADMINISTERED 42 0.0014
391 FLANK PAIN 13 0.0014
392 HYPOTHERMIA 14 0.0014
393 PANCREATITIS ACUTE 31 0.0014
394 DYSGEUSIA 102 0.0014
395 GASTROENTERITIS 20 0.0014
396 DRUG INEFFECTIVE 1805 0.0014
397 TUMOUR LYSIS SYNDROME 12 0.0014
398 IMPAIRED WORK ABILITY 29 0.0014
399 PYREXIA 469 0.0014
400 BRADYKINESIA 8 0.0014
401 POOR VENOUS ACCESS 14 0.0014
402 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
403 MUSCLE RIGIDITY 16 0.0013
404 BLOOD CALCIUM DECREASED 15 0.0013
405 POSTOPERATIVE WOUND INFECTION 9 0.0013
406 DRUG LEVEL INCREASED 22 0.0013
407 BLOOD LACTIC ACID INCREASED 7 0.0013
408 MOUTH ULCERATION 28 0.0013
409 LUNG DISORDER 65 0.0013
410 RENAL TUBULAR NECROSIS 13 0.0013
411 HYPOCALCAEMIA 25 0.0013
412 OEDEMA PERIPHERAL 160 0.0013
413 HYPERTHERMIA 10 0.0013
414 MYOCARDITIS 15 0.0013
415 UPPER GASTROINTESTINAL HAEMORRHAGE 22 0.0013
416 PNEUMONIA BACTERIAL 12 0.0013
417 COMPRESSION FRACTURE 7 0.0013
418 PANCYTOPENIA 73 0.0013
419 LYMPHOEDEMA 9 0.0013
420 NIGHTMARE 45 0.0013
421 NEUTROPHIL COUNT DECREASED 53 0.0013
422 HEAD DISCOMFORT 23 0.0013
423 LARGE INTESTINE PERFORATION 9 0.0013
424 HYPERCALCAEMIA 16 0.0013
425 BLOOD PRESSURE FLUCTUATION 31 0.0013
426 NORMAL NEWBORN 7 0.0013
427 CYSTITIS 41 0.0013
428 ILEUS 16 0.0013
429 OESOPHAGITIS 14 0.0013
430 APPLICATION SITE REACTION 9 0.0013
431 GASTROINTESTINAL INFLAMMATION 10 0.0013
432 BRAIN FOG 20 0.0013
433 WEIGHT DECREASED 355 0.0013
434 BRAIN OEDEMA 16 0.0013
435 ORTHOSTATIC HYPOTENSION 22 0.0013
436 HAEMATOTOXICITY 12 0.0013
437 BLOOD BILIRUBIN INCREASED 34 0.0013
438 SCREAMING 8 0.0013
439 MUSCULOSKELETAL STIFFNESS 110 0.0013
440 PRODUCT TASTE ABNORMAL 17 0.0013
441 POLYNEUROPATHY 15 0.0013
442 TOXIC EPIDERMAL NECROLYSIS 19 0.0012
443 DYSURIA 46 0.0012
444 SKIN INFECTION 14 0.0012
445 DEEP VEIN THROMBOSIS 81 0.0012
446 C-REACTIVE PROTEIN INCREASED 45 0.0012
447 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 21 0.0012
448 INCOHERENT 8 0.0012
449 HIATUS HERNIA 16 0.0012
450 NEUTROPENIA 168 0.0012
451 NAUSEA 975 0.0012
452 CHOKING 24 0.0012
453 ABDOMINAL DISCOMFORT 206 0.0012
454 ORAL DISCOMFORT 17 0.0012
455 HYPERTONIA 7 0.0012
456 HEPATOMEGALY 12 0.0012
457 RETCHING 26 0.0012
458 GENERALISED TONIC-CLONIC SEIZURE 20 0.0012
459 HYPERTRIGLYCERIDAEMIA 7 0.0012
460 TOXIC SKIN ERUPTION 12 0.0012
461 RESPIRATORY FAILURE 86 0.0012
462 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 12 0.0012
463 PSEUDOMONAS INFECTION 10 0.0012
464 LARGE INTESTINE POLYP 8 0.0012
465 DEHYDRATION 154 0.0012
466 PRODUCT USE IN UNAPPROVED INDICATION 286 0.0012
467 PLATELET COUNT INCREASED 15 0.0011
468 OVERDOSE 248 0.0011
469 HYPOMAGNESAEMIA 16 0.0011
470 MITRAL VALVE INCOMPETENCE 13 0.0011
471 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10 0.0011
472 ACCIDENTAL OVERDOSE 42 0.0011
473 WEIGHT FLUCTUATION 12 0.0011
474 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
475 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
476 WHEEZING 67 0.0011
477 PARKINSONISM 11 0.0011
478 CARDIO-RESPIRATORY ARREST 47 0.0011
479 ANAPHYLACTIC REACTION 62 0.0011
480 ECONOMIC PROBLEM 17 0.0011
481 ELECTROLYTE IMBALANCE 13 0.0011
482 BLOOD SODIUM DECREASED 21 0.0011
483 LACTIC ACIDOSIS 36 0.0011
484 MUSCLE DISORDER 9 0.0011
485 ALTERED STATE OF CONSCIOUSNESS 24 0.0011
486 COVID-19 PNEUMONIA 13 0.0011
487 POLYURIA 9 0.0011
488 BLOOD IRON DECREASED 13 0.0011
489 UPPER-AIRWAY COUGH SYNDROME 9 0.0011
490 ASTHENIA 408 0.0011
491 DENTAL CARIES 12 0.0011
492 NEUROTOXICITY 19 0.0011
493 LIVER DISORDER 48 0.0011
494 SEIZURE 125 0.0011
495 INTERVERTEBRAL DISC DEGENERATION 10 0.0011
496 TACHYCARDIA 96 0.0011
497 HYPERSENSITIVITY 199 0.0011
498 DELIRIUM 37 0.0011
499 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 8 0.0011
500 PNEUMONITIS 29 0.0011
501 PULMONARY CONGESTION 14 0.0011
502 NEUROPATHY PERIPHERAL 101 0.0011
503 HAEMOGLOBIN DECREASED 109 0.0011
504 TREMOR 176 0.0011
505 COVID-19 186 0.0011
506 APPETITE DISORDER 7 0.0011
507 POISONING DELIBERATE 10 0.0011
508 PETECHIAE 11 0.0011
509 OXYGEN SATURATION DECREASED 59 0.0010
510 EYE INFLAMMATION 10 0.0010
511 URINARY INCONTINENCE 31 0.0010
512 UNRESPONSIVE TO STIMULI 27 0.0010
513 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
514 BLOOD MAGNESIUM DECREASED 9 0.0010
515 INCONTINENCE 11 0.0010
516 RENAL PAIN 11 0.0010
517 HAEMOLYSIS 8 0.0010
518 PNEUMONIA 335 0.0010
519 CONCUSSION 8 0.0010
520 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
521 CARDIAC ARREST 85 0.0010
522 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 7 0.0010
523 PELVIC FRACTURE 8 0.0010
524 TORSADE DE POINTES 8 0.0010
525 RESPIRATION ABNORMAL 7 0.0010
526 SYSTEMIC LUPUS ERYTHEMATOSUS 36 0.0010
527 BLOOD PRESSURE INCREASED 155 0.0010
528 DIVERTICULITIS 28 0.0010
529 INFUSION SITE PAIN 13 0.0010
530 MENTAL STATUS CHANGES 28 0.0010
531 BALANCE DISORDER 87 0.0010
532 GASTROINTESTINAL DISORDER 90 0.0010
533 COORDINATION ABNORMAL 14 0.0010
534 HYPOTONIA 10 0.0010
535 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
536 URINARY TRACT INFECTION 170 0.0010
537 SLEEP APNOEA SYNDROME 19 0.0010
538 EATING DISORDER 21 0.0010
539 RHABDOMYOLYSIS 41 0.0010
540 POLLAKIURIA 41 0.0010
541 DECUBITUS ULCER 8 0.0010
542 SUBDURAL HAEMATOMA 14 0.0010
543 POOR QUALITY SLEEP 21 0.0010
544 HICCUPS 8 0.0010
545 ORAL HERPES 19 0.0010
546 HALLUCINATION 73 0.0010
547 VERTIGO 59 0.0010
548 MYOCARDIAL ISCHAEMIA 11 0.0010
549 EXTRAPYRAMIDAL DISORDER 24 0.0010
550 ASTHMA 109 0.0010
551 CYTOMEGALOVIRUS INFECTION 16 0.0010
552 AGGRESSION 48 0.0010
553 TACHYPNOEA 13 0.0010
554 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 28 0.0010
555 ATRIAL FIBRILLATION 93 0.0010
556 ORAL DISORDER 7 0.0010
557 SEPTIC SHOCK 41 0.0009
558 EYE PAIN 53 0.0009
559 HAEMORRHAGE INTRACRANIAL 14 0.0009
560 TINNITUS 43 0.0009
561 HIP FRACTURE 30 0.0009
562 ERUCTATION 18 0.0009
563 ATAXIA 11 0.0009
564 COMA 44 0.0009
565 RIB FRACTURE 19 0.0009
566 ACIDOSIS 7 0.0009
567 THINKING ABNORMAL 17 0.0009
568 GASTRITIS 24 0.0009
569 DEPRESSED LEVEL OF CONSCIOUSNESS 36 0.0009
570 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 184 0.0009
571 METABOLIC ACIDOSIS 29 0.0009
572 PRODUCT COMMUNICATION ISSUE 8 0.0009
573 ATRIOVENTRICULAR BLOCK 7 0.0009
574 PURPURA 8 0.0009
575 HEPATITIS 23 0.0009
576 HYPERTENSION 190 0.0009
577 DECREASED APPETITE 208 0.0009
578 FISTULA 10 0.0009
579 STATUS EPILEPTICUS 10 0.0009
580 HEADACHE 555 0.0009
581 GAIT DISTURBANCE 169 0.0009
582 PREMATURE DELIVERY 14 0.0009
583 SEDATION 23 0.0009
584 SCIATICA 14 0.0009
585 ATRIAL FLUTTER 7 0.0009
586 DYSPHAGIA 83 0.0009
587 BLOOD DISORDER 7 0.0009
588 CELLULITIS 44 0.0009
589 PLASMA CELL MYELOMA 34 0.0009
590 RHINORRHOEA 56 0.0009
591 HYPOGLYCAEMIA 42 0.0009
592 NERVOUS SYSTEM DISORDER 27 0.0009
593 PRODUCT DISTRIBUTION ISSUE 8 0.0009
594 ABNORMAL BEHAVIOUR 34 0.0009
595 DISORIENTATION 34 0.0009
596 FALL 285 0.0009
597 MENTAL DISORDER 37 0.0008
598 DIABETES MELLITUS INADEQUATE CONTROL 15 0.0008
599 ACUTE CORONARY SYNDROME 7 0.0008
600 GASTRIC ULCER 16 0.0008
601 FEELING JITTERY 16 0.0008
602 CHOLECYSTITIS 10 0.0008
603 NO ADVERSE EVENT 152 0.0008
604 BLOOD UREA INCREASED 14 0.0008
605 LETHARGY 48 0.0008
606 ELECTROCARDIOGRAM QT PROLONGED 30 0.0008
607 HEART RATE INCREASED 82 0.0008
608 HERNIA 16 0.0008
609 PRESCRIBED OVERDOSE 16 0.0008
610 EAR PAIN 16 0.0008
611 DISEASE RECURRENCE 39 0.0008
612 PHARYNGEAL SWELLING 8 0.0008
613 NASAL CONGESTION 48 0.0008
614 DYSPNOEA 462 0.0008
615 HYPOTHYROIDISM 26 0.0008
616 MUSCLE SPASTICITY 10 0.0008
617 DYSKINESIA 33 0.0008
618 MALAISE 356 0.0008
619 BRADYCARDIA 43 0.0008
620 CHILLS 95 0.0008
621 PHARMACEUTICAL PRODUCT COMPLAINT 21 0.0008
622 WHITE BLOOD CELL COUNT INCREASED 31 0.0008
623 STOMATITIS 49 0.0008
624 NIGHT SWEATS 26 0.0008
625 INTENTIONAL DOSE OMISSION 23 0.0008
626 HEPATIC STEATOSIS 15 0.0008
627 RED BLOOD CELL COUNT DECREASED 23 0.0008
628 DEPRESSION 183 0.0008
629 THROAT IRRITATION 36 0.0008
630 ARTHRITIS 63 0.0008
631 JOINT STIFFNESS 21 0.0008
632 SALIVARY HYPERSECRETION 8 0.0008
633 BLOOD CREATINE PHOSPHOKINASE INCREASED 23 0.0008
634 ANGER 27 0.0008
635 HEART RATE IRREGULAR 18 0.0008
636 DYSPNOEA EXERTIONAL 30 0.0008
637 DERMATITIS CONTACT 9 0.0008
638 PLATELET COUNT DECREASED 84 0.0008
639 NECK PAIN 44 0.0008
640 PHOTOSENSITIVITY REACTION 13 0.0008
641 SLUGGISHNESS 8 0.0008
642 DEVICE OCCLUSION 11 0.0008
643 MYOSITIS 7 0.0008
644 LEUKOPENIA 39 0.0008
645 ERYTHEMA 160 0.0008
646 OSTEOMYELITIS 14 0.0008
647 HYPERBILIRUBINAEMIA 8 0.0008
648 LIP DRY 7 0.0008
649 ACUTE MYELOID LEUKAEMIA 12 0.0008
650 DRUG INTERACTION 122 0.0008
651 HAEMORRHOIDS 15 0.0008
652 HYPERGLYCAEMIA 28 0.0008
653 WHITE BLOOD CELL COUNT DECREASED 83 0.0008
654 MUSCULAR WEAKNESS 87 0.0008
655 ALANINE AMINOTRANSFERASE INCREASED 47 0.0008
656 EXTRA DOSE ADMINISTERED 31 0.0008
657 PRODUCT ODOUR ABNORMAL 8 0.0008
658 FOLLICULITIS 8 0.0008
659 EPISTAXIS 57 0.0008
660 ANHEDONIA 20 0.0008
661 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
662 SYNCOPE 76 0.0008
663 ORAL PAIN 17 0.0008
664 FATIGUE 588 0.0008
665 EPILEPSY 23 0.0008
666 ACUTE MYOCARDIAL INFARCTION 22 0.0007
667 GASTROOESOPHAGEAL REFLUX DISEASE 60 0.0007
668 ECZEMA 39 0.0007
669 DECREASED ACTIVITY 8 0.0007
670 SCHIZOPHRENIA 9 0.0007
671 CHEST PAIN 137 0.0007
672 BONE MARROW FAILURE 15 0.0007
673 OEDEMA 40 0.0007
674 PRODUCT PRESCRIBING ISSUE 16 0.0007
675 HEPATIC ENZYME INCREASED 50 0.0007
676 ACUTE HEPATIC FAILURE 10 0.0007
677 COUGH 205 0.0007
678 RESPIRATORY TRACT INFECTION 19 0.0007
679 LOWER LIMB FRACTURE 14 0.0007
680 DIZZINESS 363 0.0007
681 SINUS BRADYCARDIA 7 0.0007
682 HOSPITALISATION 111 0.0007
683 BACK PAIN 167 0.0007
684 SECRETION DISCHARGE 9 0.0007
685 RESTLESS LEGS SYNDROME 13 0.0007
686 DEVICE RELATED INFECTION 11 0.0007
687 CARPAL TUNNEL SYNDROME 10 0.0007
688 BLOOD PRESSURE ABNORMAL 14 0.0007
689 PAIN 430 0.0007
690 PRODUCT USE COMPLAINT 11 0.0007
691 PREMATURE BABY 21 0.0007
692 HYPERSOMNIA 20 0.0007
693 NEPHROLITHIASIS 32 0.0007
694 STAPHYLOCOCCAL INFECTION 23 0.0007
695 ARRHYTHMIA 33 0.0007
696 HEAD INJURY 22 0.0007
697 FULL BLOOD COUNT DECREASED 14 0.0007
698 FEEDING DISORDER 14 0.0007
699 ABSCESS 11 0.0007
700 EUPHORIC MOOD 7 0.0007
701 METASTASES TO LIVER 12 0.0007
702 INITIAL INSOMNIA 7 0.0007
703 SARS-COV-2 TEST POSITIVE 9 0.0007
704 WOUND 19 0.0007
705 MUSCLE TIGHTNESS 11 0.0007
706 HOT FLUSH 51 0.0007
707 CARDIOMYOPATHY 10 0.0007
708 HYPOACUSIS 29 0.0007
709 SINUSITIS 69 0.0007
710 THIRST 12 0.0007
711 QUALITY OF LIFE DECREASED 9 0.0007
712 PULMONARY OEDEMA 30 0.0007
713 RASH PAPULAR 15 0.0007
714 GASTROENTERITIS VIRAL 12 0.0007
715 CHROMATURIA 15 0.0007
716 THERAPEUTIC RESPONSE SHORTENED 22 0.0007
717 KIDNEY INFECTION 13 0.0007
718 APHASIA 20 0.0007
719 BLOOD PRESSURE DECREASED 44 0.0007
720 JOINT DISLOCATION 7 0.0007
721 OSTEOARTHRITIS 28 0.0007
722 PRODUCT USE ISSUE 124 0.0007
723 ADRENAL INSUFFICIENCY 8 0.0007
724 FIBROMYALGIA 16 0.0007
725 ANXIETY 187 0.0007
726 BREAST PAIN 7 0.0007
727 CONTUSION 63 0.0007
728 CYTOPENIA 8 0.0007
729 DYSSTASIA 19 0.0007
730 CARDIOMEGALY 8 0.0006
731 SPINAL FRACTURE 13 0.0006
732 MEDICATION ERROR 36 0.0006
733 CYST 8 0.0006
734 RENAL IMPAIRMENT 54 0.0006
735 TASTE DISORDER 13 0.0006
736 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
737 PARANOIA 11 0.0006
738 BODY TEMPERATURE INCREASED 13 0.0006
739 MELAENA 14 0.0006
740 PAIN IN JAW 18 0.0006
741 FOOT FRACTURE 12 0.0006
742 CRYING 23 0.0006
743 BLOOD URINE PRESENT 12 0.0006
744 MUSCULOSKELETAL PAIN 33 0.0006
745 RESPIRATORY TRACT CONGESTION 10 0.0006
746 RASH MACULAR 22 0.0006
747 RESTLESSNESS 23 0.0006
748 GAIT INABILITY 21 0.0006
749 SEROTONIN SYNDROME 12 0.0006
750 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 16 0.0006
751 HYPERTHYROIDISM 9 0.0006
752 ILLNESS 64 0.0006
753 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
754 COGNITIVE DISORDER 29 0.0006
755 OROPHARYNGEAL PAIN 57 0.0006
756 PERIPHERAL SWELLING 94 0.0006
757 CEREBROVASCULAR ACCIDENT 103 0.0006
758 BRONCHITIS 45 0.0006
759 TOOTH INFECTION 8 0.0006
760 PERICARDIAL EFFUSION 14 0.0006
761 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
762 PANIC ATTACK 22 0.0006
763 PRESCRIBED UNDERDOSE 12 0.0006
764 PERICARDITIS 10 0.0006
765 PRODUCT PHYSICAL ISSUE 12 0.0006
766 LYMPHADENOPATHY 21 0.0006
767 FACE OEDEMA 10 0.0006
768 SINUS CONGESTION 8 0.0006
769 HEMIPARESIS 10 0.0006
770 MIDDLE INSOMNIA 11 0.0006
771 MYOCLONUS 7 0.0006
772 MIGRAINE 56 0.0006
773 AGITATION 43 0.0006
774 NEEDLE ISSUE 17 0.0006
775 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
776 FRACTURE 11 0.0006
777 CHOLELITHIASIS 19 0.0006
778 HAEMATOMA 15 0.0006
779 LOSS OF CONSCIOUSNESS 74 0.0006
780 BASAL CELL CARCINOMA 9 0.0006
781 INFLUENZA 64 0.0006
782 DISCOMFORT 35 0.0006
783 CYANOSIS 9 0.0006
784 PALPITATIONS 67 0.0006
785 PRODUCT DOSE OMISSION ISSUE 168 0.0006
786 VIRAL INFECTION 19 0.0006
787 MOBILITY DECREASED 41 0.0006
788 RESPIRATORY DISORDER 17 0.0006
789 PNEUMOTHORAX 9 0.0006
790 DEPRESSED MOOD 30 0.0006
791 TREATMENT NONCOMPLIANCE 31 0.0006
792 HALLUCINATION, AUDITORY 9 0.0006
793 MALIGNANT NEOPLASM PROGRESSION 58 0.0006
794 SHOCK 13 0.0006
795 HEPATOCELLULAR INJURY 8 0.0006
796 EAR INFECTION 15 0.0006
797 BONE PAIN 33 0.0006
798 WEIGHT INCREASED 126 0.0006
799 MUSCLE SPASMS 103 0.0006
800 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
801 MATERNAL EXPOSURE DURING PREGNANCY 50 0.0006
802 ANGINA PECTORIS 16 0.0006
803 RENAL DISORDER 26 0.0006
804 INSOMNIA 148 0.0006
805 HAEMATURIA 19 0.0006
806 CATARACT 33 0.0006
807 MUSCLE ATROPHY 7 0.0006
808 TOOTHACHE 10 0.0006
809 PAIN IN EXTREMITY 161 0.0005
810 ANAPHYLACTIC SHOCK 14 0.0005
811 METASTASES TO CENTRAL NERVOUS SYSTEM 7 0.0005
812 BONE DENSITY DECREASED 17 0.0005
813 DRUG-INDUCED LIVER INJURY 17 0.0005
814 PSYCHOTIC DISORDER 16 0.0005
815 ACNE 41 0.0005
816 DISTURBANCE IN ATTENTION 29 0.0005
817 MENTAL IMPAIRMENT 13 0.0005
818 OSTEOPOROSIS 22 0.0005
819 ADVERSE DRUG REACTION 48 0.0005
820 TOOTH LOSS 11 0.0005
821 MOVEMENT DISORDER 17 0.0005
822 GASTROINTESTINAL HAEMORRHAGE 44 0.0005
823 DERMATITIS 11 0.0005
824 INCREASED APPETITE 10 0.0005
825 AGEUSIA 13 0.0005
826 DRY EYE 26 0.0005
827 RASH 227 0.0005
828 RASH PRURITIC 28 0.0005
829 FLUID RETENTION 26 0.0005
830 ILL-DEFINED DISORDER 31 0.0005
831 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
832 PROSTATIC SPECIFIC ANTIGEN INCREASED 7 0.0005
833 CHEST DISCOMFORT 52 0.0005
834 DISEASE PROGRESSION 60 0.0005
835 SKIN ULCER 13 0.0005
836 CEREBRAL HAEMORRHAGE 18 0.0005
837 RASH ERYTHEMATOUS 24 0.0005
838 DEMENTIA 14 0.0005
839 CHRONIC KIDNEY DISEASE 38 0.0005
840 BURNING SENSATION 35 0.0005
841 HYPERHIDROSIS 64 0.0005
842 HYPOAESTHESIA 74 0.0005
843 NASOPHARYNGITIS 90 0.0005
844 METASTASES TO BONE 8 0.0005
845 HERPES ZOSTER 28 0.0005
846 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
847 VISION BLURRED 66 0.0005
848 PULMONARY HYPERTENSION 10 0.0005
849 APATHY 7 0.0005
850 LIMB INJURY 13 0.0005
851 PHOTOPHOBIA 9 0.0005
852 INFECTION 69 0.0005
853 HAEMATEMESIS 12 0.0005
854 MOOD SWINGS 15 0.0005
855 DEATH 402 0.0005
856 HYPOAESTHESIA ORAL 7 0.0005
857 JOINT SWELLING 56 0.0005
858 OCULAR HYPERAEMIA 22 0.0005
859 LACRIMATION INCREASED 14 0.0005
860 THERAPY INTERRUPTED 33 0.0005
861 AMNESIA 30 0.0005
862 PRODUCT DISPENSING ERROR 10 0.0005
863 HIP ARTHROPLASTY 7 0.0005
864 LOCALISED INFECTION 11 0.0005
865 PRURITUS 174 0.0005
866 MUSCULOSKELETAL CHEST PAIN 7 0.0005
867 ARTHRALGIA 188 0.0005
868 STEVENS-JOHNSON SYNDROME 10 0.0004
869 PREGNANCY 9 0.0004
870 HEPATOTOXICITY 10 0.0004
871 INTENTIONAL SELF-INJURY 9 0.0004
872 THERAPY NON-RESPONDER 20 0.0004
873 DRUG ABUSE 37 0.0004
874 MEMORY IMPAIRMENT 61 0.0004
875 MOOD ALTERED 12 0.0004
876 SKIN LESION 12 0.0004
877 EYE IRRITATION 25 0.0004
878 ROAD TRAFFIC ACCIDENT 18 0.0004
879 EYE DISORDER 14 0.0004
880 CARDIAC FAILURE 34 0.0004
881 NERVOUSNESS 22 0.0004
882 IRRITABLE BOWEL SYNDROME 9 0.0004
883 SKIN CANCER 9 0.0004
884 PRODUCT SUBSTITUTION ISSUE 24 0.0004
885 DYSTONIA 8 0.0004
886 FEAR 11 0.0004
887 MUSCULOSKELETAL DISCOMFORT 7 0.0004
888 RENAL FAILURE 54 0.0004
889 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
890 FOETAL EXPOSURE DURING PREGNANCY 32 0.0004
891 GALLBLADDER DISORDER 7 0.0004
892 SKIN DISCOLOURATION 18 0.0004
893 PELVIC PAIN 7 0.0004
894 MYALGIA 65 0.0004
895 THERAPEUTIC RESPONSE UNEXPECTED 17 0.0004
896 PANCREATITIS 20 0.0004
897 URTICARIA 63 0.0004
898 SURGERY 22 0.0004
899 BLOOD GLUCOSE DECREASED 18 0.0004
900 CARDIAC FAILURE CONGESTIVE 30 0.0004
901 LABORATORY TEST ABNORMAL 11 0.0004
902 MUSCULOSKELETAL DISORDER 7 0.0004
903 TOOTH DISORDER 8 0.0004
904 SKIN FISSURES 7 0.0004
905 LIMB DISCOMFORT 11 0.0004
906 FEMUR FRACTURE 11 0.0004
907 MUSCLE TWITCHING 8 0.0003
908 FEELING ABNORMAL 83 0.0003
909 FLUSHING 35 0.0003
910 DEAFNESS 9 0.0003
911 UNEVALUABLE EVENT 26 0.0003
912 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
913 PRODUCT DOSE OMISSION 22 0.0003
914 DRUG DEPENDENCE 54 0.0003
915 IMPAIRED HEALING 11 0.0003
916 WITHDRAWAL SYNDROME 14 0.0003
917 KNEE ARTHROPLASTY 7 0.0003
918 HEPATIC FAILURE 10 0.0003
919 PALLOR 9 0.0003
920 SKIN DISORDER 11 0.0003
921 SUICIDAL IDEATION 30 0.0003
922 CEREBRAL INFARCTION 8 0.0003
923 EYE PRURITUS 11 0.0003
924 PARAESTHESIA 51 0.0003
925 EMOTIONAL DISTRESS 39 0.0003
926 GASTRIC DISORDER 11 0.0003
927 PSORIATIC ARTHROPATHY 13 0.0003
928 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
929 GLYCOSYLATED HAEMOGLOBIN INCREASED 8 0.0003
930 VISUAL IMPAIRMENT 39 0.0003
931 BLOOD GLUCOSE INCREASED 59 0.0003
932 FEELING HOT 19 0.0003
933 ARTHROPATHY 17 0.0003
934 ALOPECIA 60 0.0003
935 DRUG EFFECT INCOMPLETE 11 0.0003
936 VISUAL ACUITY REDUCED 10 0.0003
937 LIP SWELLING 10 0.0003
938 JAUNDICE 8 0.0003
939 SUICIDE ATTEMPT 18 0.0003
940 HAEMORRHAGE 31 0.0003
941 THROAT TIGHTNESS 8 0.0003
942 ADVERSE EVENT 27 0.0003
943 DRY SKIN 39 0.0003
944 INFLAMMATION 15 0.0003
945 NEOPLASM PROGRESSION 10 0.0003
946 LIVER INJURY 7 0.0003
947 BLISTER 16 0.0003
948 TOXICITY TO VARIOUS AGENTS 48 0.0003
949 MULTIPLE SCLEROSIS 13 0.0003
950 INJECTION SITE MASS 10 0.0003
951 FUNGAL INFECTION 9 0.0003
952 EYE SWELLING 10 0.0003
953 INFLUENZA LIKE ILLNESS 22 0.0003
954 CARDIAC DISORDER 25 0.0003
955 IRRITABILITY 16 0.0003
956 DRUG WITHDRAWAL SYNDROME 23 0.0003
957 MYELOSUPPRESSION 9 0.0002
958 INTENTIONAL OVERDOSE 16 0.0002
959 THERAPEUTIC RESPONSE DECREASED 15 0.0002
960 INJURY 17 0.0002
961 LIVER FUNCTION TEST ABNORMAL 7 0.0002
962 SKIN EXFOLIATION 20 0.0002
963 EMOTIONAL DISORDER 7 0.0002
964 DEVICE ISSUE 19 0.0002
965 VAGINAL HAEMORRHAGE 9 0.0002
966 INTERSTITIAL LUNG DISEASE 10 0.0002
967 SKIN IRRITATION 9 0.0002
968 BLINDNESS 8 0.0002
969 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
970 RHEUMATOID ARTHRITIS 22 0.0002
971 EXPOSURE DURING PREGNANCY 12 0.0002
972 PSORIASIS 25 0.0002
973 TREATMENT FAILURE 15 0.0002
974 INJECTION SITE HAEMORRHAGE 13 0.0002
975 DEVICE LEAKAGE 7 0.0002
976 DEVICE DISLOCATION 7 0.0002
977 MULTIPLE SCLEROSIS RELAPSE 11 0.0002
978 INJECTION SITE SWELLING 12 0.0002
979 THERAPY CESSATION 8 0.0002
980 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
981 PRODUCT QUALITY ISSUE 21 0.0002
982 BREAST CANCER 13 0.0001
983 MYOCARDIAL INFARCTION 24 0.0001
984 BLADDER CANCER 8 0.0001
985 DERMATITIS ATOPIC 7 0.0001
986 DRUG DOSE OMISSION 21 0.0001
987 CONVULSION 7 0.0001
988 INJECTION SITE PRURITUS 8 0.0001
989 INJECTION SITE ERYTHEMA 14 0.0001
990 NEOPLASM MALIGNANT 7 0.0001
991 INJECTION SITE PAIN 31 0.0001
992 PROSTATE CANCER 7 0.0001